Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas E Clancy

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Cell Host & Microbe|August 20, 2013
Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironmentAleksandar D Kostic, Eunyoung Chun, Lauren Robertson, et al.
Pancreas|February 4, 2020
Predictors of Recurrence and Survival in Patients With Surgically Resected Pancreatic Neuroendocrine TumorsRachel E Rosenblum, Cynthia K Harris, Kiwoon Joshua Baeg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2014
Molecular testing for lymph node metastases as a determinant of colon cancer recurrence: results from a retrospective multicenter studyDaniel J Sargent, Qian Shi, Sharlene Gill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitusChen Yuan, Douglas A Rubinson, Zhi Rong Qian, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 23, 2021
Pancreatic acinar cell carcinoma: A multi-center series on clinical characteristics and treatment outcomesVishwajith Sridharan, Mari Mino-Kenudson, James M Cleary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2023
PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic CancerLestat R Ali, Patrick J Lenehan, Victoire Cardot-Ruffino, et al.
Gastroenterology|December 17, 2020
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early DetectionJohannes F Fahrmann, C Max Schmidt, Xiangying Mao, et al.
Science (New York, N.Y.)|November 25, 2017
Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancerSusan Bullman, Chandra S Pedamallu, Ewa Sicinska, et al.
Cell Reports. Medicine|September 20, 2023
A blood-based metabolomic signature predictive of risk for pancreatic cancerEhsan Irajizad, Ana Kenney, Tiffany Tang, et al.
Cancer Discovery|March 17, 2021
Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical OutcomeShannon M Liudahl, Courtney B Betts, Shamilene Sivagnanam, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Cell Host & Microbe|August 20, 2013
Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironmentAleksandar D Kostic, Eunyoung Chun, Lauren Robertson, et al.
Pancreas|February 4, 2020
Predictors of Recurrence and Survival in Patients With Surgically Resected Pancreatic Neuroendocrine TumorsRachel E Rosenblum, Cynthia K Harris, Kiwoon Joshua Baeg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2014
Molecular testing for lymph node metastases as a determinant of colon cancer recurrence: results from a retrospective multicenter studyDaniel J Sargent, Qian Shi, Sharlene Gill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitusChen Yuan, Douglas A Rubinson, Zhi Rong Qian, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 23, 2021
Pancreatic acinar cell carcinoma: A multi-center series on clinical characteristics and treatment outcomesVishwajith Sridharan, Mari Mino-Kenudson, James M Cleary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2023
PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic CancerLestat R Ali, Patrick J Lenehan, Victoire Cardot-Ruffino, et al.
Gastroenterology|December 17, 2020
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early DetectionJohannes F Fahrmann, C Max Schmidt, Xiangying Mao, et al.
Science (New York, N.Y.)|November 25, 2017
Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancerSusan Bullman, Chandra S Pedamallu, Ewa Sicinska, et al.
Cell Reports. Medicine|September 20, 2023
A blood-based metabolomic signature predictive of risk for pancreatic cancerEhsan Irajizad, Ana Kenney, Tiffany Tang, et al.
Cancer Discovery|March 17, 2021
Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical OutcomeShannon M Liudahl, Courtney B Betts, Shamilene Sivagnanam, et al.
Pageof 9